Barzolvolimab Phase 1b Multiple Ascending Dose Chronic Spontaneous Urticaria Study Results AAAAI 2023 | Celldex Therapeutics

background image of cells and shapes

Investors
& Media

Barzolvolimab Phase 1b Multiple Ascending Dose Chronic Spontaneous Urticaria Study Results AAAAI 2023

Feb 26, 2023 at 5:00 PM EST

Listen to webcast

Supporting Materials

View Poster 426.9 KB

View Presentation 1.6 MB